Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE OF COMMON STOCK (Details Narrative)

v3.22.1
NET LOSS PER SHARE OF COMMON STOCK (Details Narrative) - shares
6 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 12,100,626 8,813,626
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 360,000 860,000